AChE/BChE-IN-25
AChE/BChE-IN-25 (Compound 6e) is the orally active inhibitor for hAChE and eqBChE with IC50 of 7.9 nM and 0.79 nM. AChE/BChE-IN-25 exhibits antioxidant activity, that scavenges free radical with IC50 of 22.91 μM. AChE/BChE-IN-25 exhibits neuroprotective effects by reducing mitochondrial and cellular oxidative stress in the Drosophila Alzheimer's disease model. AChE/BChE-IN-25 ameliorates Scopolamine -induced spatial and cognitive memory impairment in mouse model[1].
Product Specifications
UNSPSC
12352211
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ache-bche-in-25.html
Smiles
O=C(NCCC1=CNC2=C1C=C(Cl)C=C2)OC3=CC([C@H](C)N(C)C)=CC=C3
Molecular Formula
C21H24ClN3O2
Molecular Weight
385.89
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AChE; BChE
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 / ICAM3 (CG106), CF640R conjugate, 0.1mg/mL
CD45RO (UCHL-1), CF640R conjugate, 0.1mg/mL
